KNect365 is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Zelluna Immunotherapy seeks TCR share of voice

Immunotherapy is currently one of the hottest areas in biotech, so differentiating from the crowd is a major challenge for startups in the space. Zelluna Immunotherapy CEO Miguel Forte explains to Scrip how his company intends to get share of voice in the busy TCR landscape.

Get the latest news as it happens.